Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| Dir | | 1.94M | $957.59M | - |
| Dir | | 457.6K | $226.35M | -18,410 |
| Dir | Taub Rebecca | 455.8K | $225.49M | -240 |
| Dir | | 357.8K | $177.01M | - |
| Dir | | 211.7K | $104.72M | -24,800 |
Transactions
50 transactions · page 12
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2023-11-17 | BAKER BROS. ADVISORS LP | Director | Buy | 15,638 | $175.79 | $2,748,950.97 | +0.5% | → |
| 2023-11-15 | BAKER BROS. ADVISORS LP | Director | Buy | 49,387 | $158.13 | $7,809,558.62 | +1.5% | → |
| 2023-11-14 | BAKER BROS. ADVISORS LP | Director | Buy | 107,499 | $146.99 | $15,801,021.17 | +0.4% | → |
| 2023-03-01 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Sale+OE | 10,000 | $273.24 | $2,732,438.36 | -19.0% | → |
| 2023-01-17 | Levy Richard S | Director | Sale+OE | 19,664 | $292.79 | $5,757,424.30 | -9.0% | → |